case_images: PMC9092211_01
case_images: Trend in white blood cell count (WBC) in units of 109 L. Dashed line represents administration of IVIG and steroid therapy.
case_images: CRIHEM2022-8739295.001.jpg
case_images: PMC9092211_01_CRIHEM2022-8739295.001.jpg
case_images: fig1
case_images: By hospital day four, patient continued to show rebound in her white count and platelet levels and her hemoglobin levels were starting to plateau off (Figures 1-3). On one week follow-up, the patient had repeat blood work that showed sharp decline in both her white cell and platelet levels (Figure 1 and Figure 3).
case_images: Trend in hemoglobin in units of g/dL. Dashed line represents administration of IVIG and steroid therapy.
case_images: CRIHEM2022-8739295.002.jpg
case_images: PMC9092211_01_CRIHEM2022-8739295.002.jpg
case_images: fig2
case_images: By hospital day four, patient continued to show rebound in her white count and platelet levels and her hemoglobin levels were starting to plateau off (Figures 1-3).
case_images: Trend in platelets in units of 104 muL. Dashed line represents administration of IVIG and steroid therapy.
case_images: CRIHEM2022-8739295.003.jpg
case_images: PMC9092211_01_CRIHEM2022-8739295.003.jpg
case_images: fig3
case_images: By hospital day four, patient continued to show rebound in her white count and platelet levels and her hemoglobin levels were starting to plateau off (Figures 1-3). On one week follow-up, the patient had repeat blood work that showed sharp decline in both her white cell and platelet levels (Figure 1 and Figure 3). ANC as low as 210 (Figure 3). As patient was otherwise asymptomatic, no further steroids or IVIG therapy was administered, but patient remains under close surveillance.